$2.32T
Total marketcap
$107.82B
Total volume
BTC 49.94%     ETH 15.50%
Dominance

Elicera Therapeutics AB (publ) ELIC.ST Stock

1.22 SEK {{ price }} -1.612902% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
42.81M SEK
LOW - HIGH [24H]
1.17 - 1.32 SEK
VOLUME [24H]
233.95K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.78 SEK

Elicera Therapeutics AB (publ) Price Chart

Elicera Therapeutics AB (publ) ELIC.ST Financial and Trading Overview

Elicera Therapeutics AB (publ) stock price 1.22 SEK
Previous Close 2.99 SEK
Open 2.99 SEK
Bid 2.91 SEK x N/A
Ask 2.99 SEK x N/A
Day's Range 2.91 - 2.99 SEK
52 Week Range 2.83 - 5.49 SEK
Volume 3.94K SEK
Avg. Volume 15.72K SEK
Market Cap 59.15M SEK
Beta (5Y Monthly) 0.485777
PE Ratio (TTM) N/A
EPS (TTM) -0.78 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

ELIC.ST Valuation Measures

Enterprise Value 15.58M SEK
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 25.530504
Price/Book (mrq) 1.9377836
Enterprise Value/Revenue 6.725
Enterprise Value/EBITDA -0.923

Trading Information

Elicera Therapeutics AB (publ) Stock Price History

Beta (5Y Monthly) 0.485777
52-Week Change -20.89%
S&P500 52-Week Change 20.43%
52 Week High 5.49 SEK
52 Week Low 2.83 SEK
50-Day Moving Average 3.48 SEK
200-Day Moving Average 3.82 SEK

ELIC.ST Share Statistics

Avg. Volume (3 month) 15.72K SEK
Avg. Daily Volume (10-Days) 17.07K SEK
Shares Outstanding 19.78M
Float 9.08M
Short Ratio N/A
% Held by Insiders 62.87%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -728.92%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.66%
Return on Equity (ttm) -43.45%

Income Statement

Revenue (ttm) 2.32M SEK
Revenue Per Share (ttm) 0.12 SEK
Quarterly Revenue Growth (yoy) 276.69%
Gross Profit (ttm) 1.28M SEK
EBITDA -16875764 SEK
Net Income Avi to Common (ttm) -16950344 SEK
Diluted EPS (ttm) -0.77
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 41.79M SEK
Total Cash Per Share (mrq) 2.11 SEK
Total Debt (mrq) 0 SEK
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 3.256
Book Value Per Share (mrq) 1.543

Cash Flow Statement

Operating Cash Flow (ttm) -5273422 SEK
Levered Free Cash Flow (ttm) 1.05M SEK

Profile of Elicera Therapeutics AB (publ)

Country Sweden
State N/A
City Gothenburg
Address World Trade Centre Gothenburg
ZIP 412 51
Phone 46 7 03 31 90 51
Website https://www.elicera.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 2

Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/II clinical trial for neuroendocrine tumors indications; ELC-201 for the treatment of various injectable solid tumors; ELC-301, a CAR T-cell therapy for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy for the treatment of solid tumors. Elicera Therapeutics AB (publ) has collaboration with the Josep Carreras Leukemia Research Institute to provide iTANK platform. The company was incorporated in 2014 and is based in Gothenburg, Sweden.

Q&A For Elicera Therapeutics AB (publ) Stock

What is a current ELIC.ST stock price?

Elicera Therapeutics AB (publ) ELIC.ST stock price today per share is 1.22 SEK.

How to purchase Elicera Therapeutics AB (publ) stock?

You can buy ELIC.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Elicera Therapeutics AB (publ)?

The stock symbol or ticker of Elicera Therapeutics AB (publ) is ELIC.ST.

Which industry does the Elicera Therapeutics AB (publ) company belong to?

The Elicera Therapeutics AB (publ) industry is Biotechnology.

How many shares does Elicera Therapeutics AB (publ) have in circulation?

The max supply of Elicera Therapeutics AB (publ) shares is 35.09M.

What is Elicera Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?

Elicera Therapeutics AB (publ) PE Ratio is now.

What was Elicera Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?

Elicera Therapeutics AB (publ) EPS is -0.78 SEK over the trailing 12 months.

Which sector does the Elicera Therapeutics AB (publ) company belong to?

The Elicera Therapeutics AB (publ) sector is Healthcare.

Elicera Therapeutics AB (publ) ELIC.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62